住院糖尿病患者阿司匹林使用合理性评价

Analysis on the Rationality of Aspirin in Inpatients with Diabetes

目的调研2015年10月1日~2016年3月31日在某三甲医院内分泌科住院的糖尿病患者阿司匹林的使用情况,分析其用药合理性,为促进临床合理使用该药提供参考。方法根据相关指南及文献等,分析其用药的适宜性;通过观察患者院内不良反应的发生情况,分析其用药的安全性。结果本研究共纳入204例患者。按照指南,对已发生过心血管疾病或有高危心血管风险的患者均应使用阿司匹林,但此次研究中,这两类患者阿司匹林的实际使用率为62.50%;阿司匹林肠溶片按说明书应餐前服药,但住院患者仍有约23%的医嘱为餐后服药;多位患者的医嘱中均有药物与阿司匹林存在相互作用,但临床治疗中并未观察到不良事件;院内使用阿司匹林的患者发生不良反应的比例仅有1.83%。结论住院患者使用阿司匹林的适宜性有待进一步提高;患者使用日剂量100 mg阿司匹林的安全性较好。

OBJECTIVE To investigate the use of aspirin in patients hospitalized in department of endocrinology from October 1st, 2015 to March 31th, 2016 and analyze the rationality use of aspirin to promote the proper use. METHODS The appropriateness of aspirin use was analyzed according to relevant guidelines, literature etc. And the safety was analyzed through observing the incidence of adverse drug reaction（ADR）. RESULTS The 204 patients were included. For patients with cardiovascular disease or with high cardiovascular risk, aspirin should be used according to guidelines. But the actual utilization rate of aspirin was 62. 50% in these two kinds of patients. About 23% of patients used aspirin after a meal which should be used on an empty stomach based on instruction. Al- though these patients used some drugs that could interact with aspirin, no adverse events observed during hospitalization. For inpatients who used aspirin, the proportion of ADR was only 1.83%. CONCLUSION Rational use of aspirin need to be further improved, the safety of 100 mg aspirin is good.